AI assistant
Sending…
ANGIODYNAMICS INC — Director's Dealing 2021
Dec 30, 2021
32939_dirs_2021-12-30_d312ec89-2e1d-4b8f-b304-8a6a05268971.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2021-07-14
Reporting Person: Trowbridge Stephen A (EVP and CFO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-07-21 | Non-Qualified Stock Option (right to buy) | $26.49 | A | 20128 | Acquired | 2031-07-21 | Common Stock (20128) | Direct |
Footnotes
F1: On July 23, 2021, the reporting person filed a Form 4 to report, among other items, the granting of stock options of AngioDynamics, Inc., which contained an administrative error as to the exercise price of such options.
F2: The exempt disposition of 354 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2019.
More from ANGIODYNAMICS INC
Regulatory Filings
2026
Apr 23
Interim / Quarterly Report
2026
Apr 2
Regulatory Filings
2026
Apr 2
Major Shareholding Notification
2026
Mar 26
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 10
Regulatory Filings
2026
Feb 3
Regulatory Filings
2026
Jan 14
Major Shareholding Notification
2026
Jan 8
Regulatory Filings
2026
Jan 6